Literature DB >> 21113766

Physical activity and genitourinary cancer survivorship.

Daniel A Galvão1, Dennis R Taaffe, Nigel Spry, Robert U Newton.   

Abstract

In this chapter we discuss common toxicities arising from genitourinary cancer treatments, in particular the adverse effects from androgen deprivation therapy (ADT) for prostate cancer given its well established detrimental effects on physical, physiological, and psychological function, and existing physical activity research in the postdiagnosis period including studies focusing on supportive care and some limited data on disease outcomes. Overall, consistent positive outcomes have been reported across studies showing that exercise is beneficial to reduce a number of treatment-related toxicities and improve symptoms. Additional studies are needed in genitourinary cancers other than prostate to establish specific physical activity requirements and implementation strategies.

Entities:  

Mesh:

Year:  2011        PMID: 21113766     DOI: 10.1007/978-3-642-04231-7_9

Source DB:  PubMed          Journal:  Recent Results Cancer Res        ISSN: 0080-0015


  5 in total

1.  Sexuality and exercise in men undergoing androgen deprivation therapy for prostate cancer.

Authors:  K Hamilton; S K Chambers; M Legg; J L Oliffe; P Cormie
Journal:  Support Care Cancer       Date:  2014-07-10       Impact factor: 3.603

Review 2.  Exercise therapy for sexual dysfunction after prostate cancer.

Authors:  Prue Cormie; Robert U Newton; Dennis R Taaffe; Nigel Spry; Daniel A Galvão
Journal:  Nat Rev Urol       Date:  2013-10-08       Impact factor: 14.432

3.  Development of a computer-tailored physical activity intervention for prostate and colorectal cancer patients and survivors: OncoActive.

Authors:  R H J Golsteijn; C Bolman; E Volders; D A Peels; H de Vries; L Lechner
Journal:  BMC Cancer       Date:  2017-06-26       Impact factor: 4.430

4.  Can exercise delay transition to active therapy in men with low-grade prostate cancer? A multicentre randomised controlled trial.

Authors:  Daniel A Galvão; Dickon Hayne; Mark Frydenberg; Suzanne K Chambers; Dennis R Taaffe; Nigel Spry; Paul A Scuffham; Robert S Ware; Nicolas H Hart; Robert U Newton
Journal:  BMJ Open       Date:  2018-04-20       Impact factor: 2.692

5.  Improving sexual health in men with prostate cancer: randomised controlled trial of exercise and psychosexual therapies.

Authors:  Prue Cormie; Suzanne K Chambers; Robert U Newton; Robert A Gardiner; Nigel Spry; Dennis R Taaffe; David Joseph; M Akhlil Hamid; Peter Chong; David Hughes; Kyra Hamilton; Daniel A Galvão
Journal:  BMC Cancer       Date:  2014-03-18       Impact factor: 4.430

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.